載入...
The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
Women receiving neoadjuvant systemic therapy for primary operable or inoperable breast cancer can potentially benefit in a number of ways, but the main advantage, which has been consistently demonstrated, is improved tumour resectability. Given the improvement in outcomes with the adjuvant use of tr...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Multimed Inc.
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768514/ https://ncbi.nlm.nih.gov/pubmed/19862361 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|